Impact of Treatment With Trifluridine/Tipiracil in Combination With Bevacizumab on Health-Related Quality of Life and Performance Status in Refractory Metastatic Colorectal Cancer: An Analysis of the Phase III SUNLIGHT Trial

by on 29 de setembre de 2025 with No hi ha comentaris
  • Taieb, J., Fakih, M., Tabernero, J., Ciardiello, F., Van Cutsem, E., Soler, G.,…Prager, G. (2025). Impact of Treatment With Trifluridine/Tipiracil in Combination With Bevacizumab on Health-Related Quality of Life and Performance Status in Refractory Metastatic Colorectal Cancer: An Analysis of the Phase III SUNLIGHT Trial. Clinical Colorectal Cancer, 24(2). https://doi.org/10.1016/j.clcc.2024.12.002

Deixa un comentari

L'adreça electrònica no es publicarà. Els camps necessaris estan marcats amb *